Skip to main content

Table 3 Multivariate analysis of factors affecting distant metastasis

From: Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

  Odds Ratio 95 % CI p-value
Age 1.046 0.999–1.095 0.054
Gender 0.688 0.197–2.401 0.557
Tumor size 1.04 0.999–1.095 0.083
Histologic type 0.816 0.182–3.66 0.790
Pathologic T stage 0.142 0.005–4.016 0.252
Extrathyroidal extension 19.535 0.618–617.017 0.091
Pathologic N stage 0.922 0.141–6.053 0.933
Lateral lymph node metastasis 11.159 1.902–65.461 0.008
TERT promoter mutation 155.298 3.362–999.990 0.009
BRAF V600E mutation 0.083 0.021–0.327 <0.001